These compounds aim to suppress Th17 differentiation and inhibit the production of pro-inflammatory cytokines like IL-17A and IL-17F, which are significant contributors to skin inflammation and keratinocyte hyperproliferation in conditions like psoriasis [105]. Here, IL17A is linked to dermatitis.